Fluorescence in situ hybridization for detecting transitional cell carcinoma: Implications for clinical practice

BJU International

Volumn 96, Issue 9, 2005, Pages 1280-1285

  Laudadio, Jennifer ^a   Keane, Thomas E ^a   Reeves, Hugh M ^a   Savage, Stephen J ^a   Hoda, Rana S ^a   Lage, Janice M ^a   Wolff, Daynna J ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Detection; Fluorescence in situ hybridization (FISH); TCC; Urothelial carcinoma; UroVysion

Indexed keywords

ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CLINICAL PRACTICE; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSITIONAL CELL CARCINOMA; TUMOR BIOPSY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 28544443486     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2005.05826.x     Document Type: Article

References (16)

1. Greenlee R, Hill-Harmon M, Murray T, Thun M. Cancer statistics. CA Cancer J Clin 2001; 51: 15-36
2. Veeramachaneni R, Nordberg ML, Shi R, Herrera GA, Turbat-Herrera EA. Evaluation of fluorescence in situ hybridization as an ancillary tool to urine cytology in diagnosing urothelial carcinoma. Diagn Cytopathol 2003; 28: 301-7
3. Veeramachaneni R, Nordberg M, Turbat-Herrera E, Herrera G. Fluorescence in situ hybridization as an ancillary tool in urine cytology to diagnose urothelial carcinoma. Pathol Case Rev 2002; 7: 70-4
4. Bubendorf L, Grilli B, Sauter G, Mihatsch MJ, Gasser TC, Dalquen P. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol 2001; 116: 79-86
5. Greene LF, Hanash K, Farrow G. Benign papilloma or papillary carcinoma of the bladder? J Urol 1973; 110: 205-7
6. Saad A, Hanbury D, McNicholas T, Boustead GB, Morgan S, Woodman AC. A study comparing various noninvasive methods of detecting bladder cancer in urine. BJU Int 2002; 89: 369-73
7. Walker L, Liston TG, LLoyd-Davies RW. Does flexible cystoscopy miss more tumours than rod-lens examination? Br J Urol 1993; 72: 449-50
8. Bastacky S, Ibrahim S, Wilczynski SP, Murphy WM. The accuracy of urinary cytology in daily practice. Cancer 1999; 87: 118-28
9. Hailing KC, King W, Sokolova I et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol 2000; 164: 1768-75
10. Wiener HG, Vooijs GP, van't Hof-Grootenboer B. Accuracy of urinary cytology in the diagnosis of primary and recurrent bladder cancer. Acta Cytol 1993; 37: 163-9
11. Sokolova IA, Hailing KC, Jenkins RB et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn 2000; 2: 116-23
12. Kruger S, Mess F, Bohle A, Feller AC. Numerical aberrations of chromosome 17 and the 9p21 Locus are independent predictors of tumor recurrence in noninvasive transitional cell carcinoma of the urinary bladder. Int J Oncol 2003; 23: 41-8
13. Hailing KC. Vysis UroVysion for the detection of urothelial carcinoma. Expert Rev Mol Diagn 2003; 3: 507-19
14. Skacel M, Fahmy M, Brainard JA et al. Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology. J Urol 2003; 169: 2101-5
15. Pycha A, Lodde M, Comploj E et al. Intermediate-risk urothelial carcinoma: an unresolved problem? Urology 2004; 63: 472-5
16. Friedrich MG, Toma MI, Hellstern A et al. Comparison of multitarget fluorescence in situ hybridization in urine with other noninvasive tests for detecting bladder cancer. BJU Int 2003; 92: 911-4